Replies to post #309106 on Avid Bioservices Inc (CDMO)

[biopharm]

I figured you would say that so it is strange one is invested in Immunotherapy with PS Targeting, that offers great safety profile on 1,000+ patients and no off target TOXICITIES re: Dr Jeff Wolchok collaborations......

And we have others pipelines WITH much TOXICITIES that market cap sits much higher and here one shouts no way, not Peregrine...

Almost as if one would want a change of the BOD and then if it happens with no other pipeline changes can credit the BOD shake up...

We shall see I guess.....